Validation study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese population

Oliveira, Ana; Santos, Isabel M.; Fernandes, Sofia; Bem-Haja, Pedro; Torres, Ana

doi:10.1186/s40359-022-01018-w

Cited by 5 publications

(1 citation statement)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Im wyższy wynik, tym zaburzenie wydaje się bardziej nasilone. Maksymalnie można uzyskać 148 pkt [24].…”

Section: Funkcjonalna Ocena Terapii Przeciwnowotworowej -Funkcje Pozn...unclassified

Diagnosis of chemotherapy-related cognitive impairment

Dunaj¹,

Piechowicz²,

Kołodziejczyk³

et al. 2022

View full text Add to dashboard Cite

Zaburzenia poznawcze mogą być skutkiem chemioterapii stosowanej wśród pacjentów onkologicznych. Ta dolegliwość, inaczej zwana chemobrain, obniża jakość codziennego życia wydłużonego dzięki chemioterapeutykom. Wydaje się za to odpowiadać neurotoksyczność stosowanych leków, skutkująca zaburzeniem struktury i funkcji tkanki nerwowej ośrodkowego układu nerwowego. Powstałe zmiany patologiczne są możliwe do wykrycia podczas właściwie przeprowadzonego procesu diagnostycznego. Obecnie nie istnieją konkretne wytyczne diagnostyki chemobrain, jednak obiecujące wydaje się wykorzystanie metod z zakresu psychologii, diagnostyki laboratoryjnej i obrazowej. Badania psychologiczne za pomocą wystandaryzowanych kwestionariuszy pozwalają obiektywnie ocenić objawy dysfunkcji poznawczych zgłaszane przez pacjenta. Analiza laboratoryjna płynów ustrojowych umożliwia wykrycie charakterystycznych biomarkerów, natomiast obrazowanie struktur ośrodkowego układu nerwowego pozwala wskazać patologiczne zmiany w regionach mózgu, skutkujące powstaniem opisywanych zaburzeń. Kluczową rolę w postawieniu właściwego rozpoznania klinicznego odgrywa badanie podmiotowe i przedmiotowe pacjenta onkologicznego po przebytej chemioterapii. Im wcześniej zostanie stwierdzone zaburzenie funkcji poznawczych, tym większa szansa osiągnięcia sukcesu terapeutycznego z zastosowaniem obecnie proponowanych metod leczniczych. W niniejszej publikacji przedstawiono przegląd dostępnej literatury na temat stosowanych metod diagnostyki chemobrain.

show abstract

“…Im wyższy wynik, tym zaburzenie wydaje się bardziej nasilone. Maksymalnie można uzyskać 148 pkt [24].…”

Section: Funkcjonalna Ocena Terapii Przeciwnowotworowej -Funkcje Pozn...unclassified

Diagnosis of chemotherapy-related cognitive impairment

Dunaj¹,

Piechowicz²,

Kołodziejczyk³

et al. 2022

View full text Add to dashboard Cite

show abstract

The Mediating Effect of Coping Style in the Relationship Between Sleep Quality and Perceived Cognitive Impairment Among Breast Cancer Patients

Chen,

Li,

Zhu

et al. 2024

Cancer Nurs

View full text Add to dashboard Cite

Background Perceived cognitive impairment is a significant symptom experienced by breast cancer patients and may be affected by sleep quality. Coping styles have potential relevancies with both sleep quality and perceived cognitive impairment. However, the empirical evidence supporting their association among breast cancer patients is limited. Objective This study explored the associations between sleep quality, coping styles, and perceived cognitive impairment and tested the mediating role of coping styles in breast cancer patients. Methods A total of 294 breast cancer patients were included in this cross-sectional study. Patients were assessed using the Pittsburgh Sleep Index Scale, the Simplified Coping Styles Questionnaire, and the Functional Assessment of Cancer Therapy-Cognitive Functioning (Version 3) Scale. The data were analyzed using SPSS and Process macros. Results The direct effect of sleep quality on reported cognitive impairment was significant (β = −0.245, P < .001). Furthermore, sleep quality was found to have a significant indirect effect on perceived cognitive impairment through positive coping style (β = −0.026, P < .05) and negative coping style (β = −0.131, P < .05). Conclusions Our research suggests that sleep quality has both a direct effect on perceived cognitive impairment and an indirect effect through positive and negative coping styles in breast cancer patients. Moreover, negative coping style had a more pronounced mediating effect than positive coping style. Implications for Practice Clinical medical staff could reduce the perceived cognitive impairment of breast cancer patients by improving their sleep quality and encouraging them to adopt a more positive coping style.

show abstract

Cognitive-enhanced eHealth psychosocial stepped intervention for managing breast cancer-related cognitive impairment: Protocol for a randomized controlled trial

Serra-Blasco,

Souto-Sampera,

Medina

et al. 2024

DIGITAL HEALTH

View full text Add to dashboard Cite

Introduction Breast cancer often leads to cancer-related cognitive impairment (CRCI), which includes both objective and subjective cognitive deficits. While psychosocial interventions benefit quality of life and distress reduction, their impact on cognitive deficits is uncertain. This study evaluates the integration of a cognitive module into a digital psychosocial intervention for breast cancer patients. Methods In this randomized controlled trial (RCT), 88 recently diagnosed breast cancer (BC) patients will receive the ICOnnecta't program (control group) – a digital stepped intervention addressing a variety of psychosocial needs. The experimental group ( n = 88) will receive ICOnnecta’t plus a cognitive module. Assessments at baseline, 3, 6, and 12 months will measure the interventions’ impact on cognition, emotional distress, medication adherence, quality of life, post-traumatic stress, work functioning and healthcare experience. Feasibility and cost-utility analyses will also be conducted. Results The cognitive module includes three levels. The first level contains a cognitive screening using FACT-Cog Perceived Cognitive Impairment (PCI). Patients with PCI <54 progress to a cognitive psychoeducational campus (Level 2) with content on cognitive education, behavioural strategies and mindfulness. Patients with persistent or worsened PCI (≥6) after 3 months move to Level 3, an online cognitive training through CogniFit software delivered twice a week over 12 weeks. Conclusions This study assesses whether integrating a cognitive module into a digital psychosocial intervention improves objective and subjective cognition in breast cancer patients. Secondary outcomes explore cognitive improvement's impact on psychosocial variables. The research will contribute to testing efficacious approaches for detecting and addressing cognitive dysfunction in breast cancer patients. Trial registration ClinicalTrials.gov, NCT06103318. Registered 26 October 2023, https://classic.clinicaltrials.gov/ct2/show/NCT06103318?term=serra-blasco&draw=2&rank=4

show abstract

Validation study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese population

Cited by 5 publications

References 41 publications

Diagnosis of chemotherapy-related cognitive impairment

Diagnosis of chemotherapy-related cognitive impairment

The Mediating Effect of Coping Style in the Relationship Between Sleep Quality and Perceived Cognitive Impairment Among Breast Cancer Patients

Cognitive-enhanced eHealth psychosocial stepped intervention for managing breast cancer-related cognitive impairment: Protocol for a randomized controlled trial

Contact Info

Product

Resources

About